| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $846.0M | — | +5.9% |
| Cost of Revenue | $634.0M | — | +2.6% |
| Gross Profit | $212.0M | — | +17.1% |
| R&D Expense | $31.0M | — | +10.7% |
| SG&A Expense | $130.0M | — | +11.1% |
| Operating Income | $77.0M | — | +30.5% |
| Pre-tax Income | $77.0M | — | +32.8% |
| Income Tax | $15.0M | — | +87.5% |
| Net Income | $62.0M | — | +24.0% |
| EPS (Basic) | $0.23 | — | +21.1% |
| EPS (Diluted) | $0.23 | — | +21.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $328.0M | -49.3% | -13.7% |
| Accounts Receivable | $324.0M | -3.0% | +27.6% |
| Inventory | $371.0M | +5.4% | -3.6% |
| Current Assets | $2.06B | -11.6% | -0.7% |
| Total Assets | $4.21B | -6.1% | +2.8% |
| Current Liabilities | $1.10B | -10.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$66.0M | — | +52.2% |
| Capital Expenditures | $30.0M | — | -6.3% |
| Investing Cash Flow | -$29.0M | — | +9.4% |
| Financing Cash Flow | -$224.0M | — | -366.7% |
| Free Cash Flow | -$96.0M | — | +43.5% |
| +7.6% |
| Long-term Debt | $140.0M | -59.8% | -58.2% |
| Stockholders' Equity | $2.77B | +1.5% | +7.7% |